Revisions to FDA Guidance: clinical decision support; digital products - The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard

The Research, Development, and Regulatory Roundtable (R3) is a forum to discuss pre-competitive issues in drug and device development, regulatory oversight of clinical trials, and human subjects research. Meetings convene policymakers, legal counsel, academicians, industry representatives, and global regulators. The R3 is a cooperative endeavor coordinated by the MRCT Center and Ropes & Gray LLP.

This hybrid meeting is open to sponsors and select guests of the Research, Development, and Regulatory Roundtable.

Topic: Revisions to FDA Guidance: clinical decision support; digital products

For more information, please email at MRCT@BWH.HARVARD.EDU

Deliverables